Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) will announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($2.52) per share for the quarter. Parties that wish to listen to the company’s conference call can do so using this link.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its quarterly earnings results on Thursday, March 28th. The basic materials company reported ($2.48) EPS for the quarter, topping the consensus estimate of ($2.68) by $0.20. Arcadia Biosciences had a negative net margin of 246.80% and a negative return on equity of 81.56%. The firm had revenue of $1.17 million for the quarter, compared to analyst estimates of $1.80 million.
Arcadia Biosciences Price Performance
NASDAQ RKDA opened at $2.01 on Wednesday. The company has a fifty day moving average of $2.24 and a two-hundred day moving average of $2.67. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $7.30. The company has a market capitalization of $2.73 million, a PE ratio of -0.14 and a beta of 0.62.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on Arcadia Biosciences
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Featured Stories
- Five stocks we like better than Arcadia Biosciences
- How to Calculate Return on Investment (ROI)
- Garmin Navigates to New Highs Driven By Wearables Trend
- What Investors Need to Know About Upcoming IPOs
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How to Buy Cheap Stocks Step by Step
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.